For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

When the iPhone debuted, critics said thumbs couldn’t type on glass. Steve Jobs disagreed. People did learn. But with tech ...

Liu described the CAR-like T cells as cytokine-activated lymphocytes engineered with the tumor-targeting and -penetrating ...

Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new ...

EU leaders couldn’t be more blatant about it if they tried. They have worked out that Nigel Farage is highly likely to be ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic ...

Researchers at Yale University School of Medicine (YSM) have discovered two proteins on the surface of motor neurons in the ...

January 12, 2026. Infinitusbio.AI, a U.S.-based Pharmatech company and creator of the proprietary Simulative AI Digital Cell Clone platform, and Oncovita, a Paris-based biotechnology company spun out ...

Stress is the body's natural response to everyday difficulties and challenges, which can even be beneficial in the short term ...

See our top 10 most-read science, research and technology stories from this year, featuring ‘Nobel Prize-worthy’ theabrownin, ...

I drove the Ford Mustang Mach-E Rally and Hyundai Ioniq 5 XRT back-to-back. Here’s which electric adventure crossover ...

Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive ...